In the current study, we demonstrate that oral treatment with selective serotonin reuptake inhibitors (SSRI) leads to modulation of vagus nerve activity and that intact vagal signaling between the gut and brain is required to mediate the behavioral effects of these drugs in the tail suspension test (TST), a commonly used screen for potential antidepressants.… Continuar lendo Oral selective serotonin reuptake inhibitors activate vagus nerve dependent gut-brain signalling.